8-K: Danimer Scientific Announces Second Quarter 2024 Results, Expects PHA Revenue to Triple by Mid-2025
Quarterly Report
Danimer Scientific reported a decrease in second quarter revenue compared to the previous year, but anticipates significant growth in PHA revenue by mid-2025 and has taken steps to deleverage its balance sheet.
Summary
- Danimer Scientific announced its financial results for the second quarter of 2024, showing a revenue of $7.6 million, down from $12.9 million in the same quarter of 2023.
- The decrease in revenue was primarily due to a $2.5 million drop in PHA revenue and a $2.4 million decrease in PLA revenue.
- The PHA revenue decline was attributed to the reapportionment of Starbucks' straw business, leading to excess inventory with converter partners.
- PLA revenue decreased due to lost orders from customers affected by the conflict in Ukraine.
- Gross profit was $(6.9) million, consistent with the $(6.6) million in the second quarter of 2023, while adjusted gross profit was $(1.8) million compared to $(1.6) million in the prior year.
- Adjusted EBITDA improved slightly to $(9.9) million from $(10.2) million in the second quarter of 2023.
- The company has a total debt of $393.9 million, including $45.7 million in low-interest New Markets Tax Credit loans expected to be forgiven starting in 2026.
- Danimer has a $20 million asset-based lending agreement, with $5.2 million borrowed as of June 30, 2024.
- A pro-rata warrant dividend transaction was completed, allowing the company to retire $6.1 million of its convertible notes.
- The company expects annualized PHA revenues to more than triple by the end of the second quarter of 2025, driven by existing customer demand, including a 20-million-pound cutlery award.
- Full-year Adjusted EBITDA is now projected to be between $(30) million and $(35) million.
- Capital expenditures are expected to remain in the $8 million to $10 million range.
- Year-end liquidity is projected to be between $15 million and $20 million.
Sentiment
Score: 5
Explanation: The document presents mixed signals. While there are positive developments like the potential for significant PHA revenue growth and debt reduction, the current financial results are weak with decreased revenue and a gross loss. The company is still operating at a loss and has a substantial debt, which tempers the positive outlook.
Positives
- Adjusted EBITDA showed a slight improvement compared to the same quarter last year.
- The company successfully retired $6.1 million of convertible notes, improving the balance sheet.
- Danimer anticipates a significant increase in PHA revenue, projecting it to more than triple by mid-2025.
- The 20-million-pound cutlery award is progressing with initial orders received and expected to reach full run rate in mid-2025.
- The company has secured a $20 million asset-based lending agreement to manage liquidity.
Negatives
- Second quarter revenue decreased significantly compared to the same period last year.
- PHA revenue declined due to the reapportionment of the Starbucks straw business.
- PLA revenue decreased due to the conflict in Ukraine.
- The company reported a gross loss of $(6.9) million for the quarter.
- The company is still operating at a loss with an adjusted EBITDA of $(9.9) million for the quarter.
- The company has a substantial debt of $393.9 million.
Risks
- The reapportionment of the Starbucks straw business is expected to continue to impact revenue into the third quarter, although to a lesser degree.
- The conflict in Ukraine continues to affect PLA sales.
- The company's ability to achieve its projected revenue growth depends on the successful ramp-up of the 20-million-pound cutlery award.
- The company faces risks related to general economic conditions, customer financial strength, and the ability to expand production facilities.
- There are risks associated with the company's ability to protect its intellectual property and maintain its information systems.
- The company's financial performance is subject to fluctuations in raw material prices and foreign currency exchange rates.
Future Outlook
The company anticipates that headwinds from the Starbucks reapportionment will continue into the third quarter but with a much lower impact. They are forecasting annualized PHA revenues to more than triple by the end of the second quarter of 2025. Full-year Adjusted EBITDA is now expected to be in the range of $(30) million to $(35) million. Year-end liquidity is projected to be between $15 million and $20 million.
Management Comments
- Stephen E. Croskrey, Chief Executive Officer of Danimer, stated that the second quarter results were in line with expectations considering the temporary impact of Starbucks' reapportionment of their Nodax-based straw business.
- Mr. Croskrey reiterated that the company has retained 100% of the Starbucks business and remains on track to grow their PHA business during 2024.
- Mr. Croskrey noted that the 20-million-pound cutlery award is progressing with initial orders received and expected to reach full run rate in mid-2025.
- Mr. Croskrey highlighted that the pro-rata warrant dividend transaction has provided a potential new avenue to deleverage the balance sheet.
Industry Context
The bioplastics industry is focused on developing sustainable alternatives to traditional plastics. Danimer's focus on PHA and biodegradable materials aligns with this trend. The company's challenges with revenue and profitability highlight the competitive pressures and operational complexities in this sector. The company's focus on securing large contracts, such as the 20-million-pound cutlery award, is a common strategy in the industry to drive growth.
Comparison to Industry Standards
- Danimer's revenue decline contrasts with some other bioplastics companies that have shown growth, although direct comparisons are difficult due to varying product focuses and market positions.
- Companies like Novamont and NatureWorks, which also produce bioplastics, have reported varying levels of success in different markets, highlighting the diverse challenges in the industry.
- Danimer's adjusted EBITDA of $(9.9) million for the quarter is not unusual for a company in the growth phase of the bioplastics industry, where significant investments in R&D and production capacity are common.
- The company's debt of $393.9 million is relatively high compared to some peers, but this is not uncommon for companies that have invested heavily in capital expenditures.
- The projected tripling of PHA revenue by mid-2025 is an ambitious target, and its success will be a key indicator of the company's competitive position in the market.
Stakeholder Impact
- Shareholders may be concerned about the decreased revenue and ongoing losses, but encouraged by the potential for future growth and debt reduction.
- Employees may be affected by the company's cost control initiatives and strategic reorganization.
- Customers may be impacted by the company's ability to meet demand for its products, particularly with the ramp-up of the cutlery award.
- Suppliers may be affected by the company's financial performance and its ability to pay for raw materials.
- Creditors may be concerned about the company's high debt levels, but reassured by the deleveraging efforts.
Next Steps
- The company will host a webcast and conference call on August 8, 2024, to discuss the second quarter results.
- The company will continue to focus on ramping up production for the 20-million-pound cutlery award.
- The company will continue to explore additional avenues to manage its liquidity position.
- The company will work towards achieving its projected tripling of PHA revenue by mid-2025.
Key Dates
| Date | Description |
|---|---|
| May 13, 2024 | Record date for the pro-rata warrant dividend distribution. |
| April 19, 2024 | Date the company entered into a $20 million asset-based lending agreement. |
| June 30, 2024 | End of the second quarter for which financial results are reported. |
| July 12, 2024 | Date the company distributed warrants to stockholders. |
| August 8, 2024 | Date of the earnings announcement and conference call. |
Keywords
PHA, bioplastics, biodegradable, revenue, EBITDA, debt, warrants, convertible notes, liquidity, sustainability
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.